Applications invited for B. ED Special Education- Multiple Disabilities
Applications are invited for a two year course in B.Ed in Special education – Multiple disabilities offered by Vidya Sagar, a 40-year-old, Chennai-based organisation working with people with disabilities. It is a full time regular course, on completion of which, the graduate can work in a mainstream school or a special school, start their own rehab center, take up Teacher Eligibility Test for government jobs, or do higher studies and get into research. This course is affiliated to the Tamil Nadu Teacher Education University, has the equivalence of B.Ed General education and is recognised by the Rehabilitation Council of India. To know more, contact 9840035203 or mail hrd@vidyasagar.co.in
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Time of India
an hour ago
- Time of India
From pimples to peptides: How Gen Z turned the dermatologist into a beauty guru
Dermatology clinics are the new beauty salons. Consumers in urban India are no longer walking into a dermat's office with just eczema, psoriasis or some other chronic skin condition. They are increasingly consulting the dermatologist for everyday skin requirements, from dealing with pimples and dandruff to enhancing the skin texture and glow. The trend is mostly driven by teenagers and young adults, but older people, both women and men, are too seeking expert medical help for skin conditions that previously were managed with home remedies. Last year, Suresh (name changed to protect privacy) rushed to a South Delhi dermatologist, worried about pimples—'Can adults get pimples?' was one of his questions to the doctor. The 41-year-old was anxious that it would affect his looks at social engagements. The treatment cost him ₹20,000. 'The stigma around seeking help for 'non-serious' skin concerns has also faded,' says Bengaluru-based Priyanka Reddy, chief dermatologist and founder of DNA Skin Clinic, who has 556,000 followers on Instagram. People today are far more informed about skin health than they were ever before, thanks to social media, beauty influencers and easy access to medical info online. Live Events Both Indian and international companies have been focusing on science-backed skincare brands for a few years now. From Minimalist, now owned by Unilever, to Cetaphil, CeraVe and Honasa Consumer-owned The Derma Co, many brands are vying for the same section of the skincare market: the young and informed consumer. 'We've seen a noticeable uptick in both age groups (Gen Z and Gen Alpha),' says Chytra Anand, dermatologist and founder of Kosmoderma, a Bengaluru-based chain of dermatology clinics. Evidence-based Self-care 'In fact, teens and young adults now make up nearly 20% of new consultations at our clinics. For the 12–18 age group, the top concern is acne—mostly hormonal and sometimes compounded by lifestyle issues like diet, screen time, and stress. There's a growing interest in skin texture and glow, thanks again to beauty influencers and filter-free selfies,' adds Anand. Young consumers are taking 'picture-perfect' quite literally. According to Alok Malik, president and business head - India Formulations at Glenmark Pharmaceuticals , the rise in dermatologist consultations is not just a medical trend; it reflects a broader shift towards evidence-based self-care. 'We are seeing increased usage, which is intentional and informed adoption, with consumers actively choosing science-backed skincare over cosmetic hype,' he says. Known for brands like Maxrich YU, Episoft, Bontress and La Shield Kids, Glenmark has been pushing the prescription vs OTC line of skincare for years now. It is using a combination of dermatological recommendations and modern retail inclusive of ecommerce to reach the target audience. Dermatologists charge ₹1,000–4,000 or more for a visit in India's major cities. This is just the consultation fee. Chances are the doctor will prescribe serums with active ingredients, moisturisers and face wash—a three-four step routine based on products which would cost another ₹10,000 or more. 'Earlier, people would only see a dermatologist for chronic conditions like acne, eczema, or pigmentation that had persisted for years. Now, even a new pimple, suntan, or mild sensitivity prompts a visit, and rightly so,' adds Reddy. 'Skin is our largest organ, and people are beginning to treat it with the same seriousness they give to diet or fitness.' While this is still a fairly urban phenomenon, market research company Statista estimates India's skin treatments market to reach about $895 million (nearly ₹7,750 crore) this year. More than 64% of the customers of Foxtale, a Mumbai-based skincare startup, are Gen Z and the older edge of Gen Alpha — 'those just stepping into their teenage years', says Romita Mazumdar, its CEO and founder. 'On our website, we've seen a 2x increase in ingredient-specific search terms in the last year alone; terms like 'niacinamide', 'glycolic acid' and 'peptides' are constantly searched,' she says. 'Even parents are encouraging early visits, which is great. I've had 15-year-olds ask if they should combine azelaic acid with niacinamide, and college students worried about barrier repair after using too many actives,' says Anand.
The Hindu
6 hours ago
- The Hindu
Applications invited for B. ED Special Education- Multiple Disabilities
Applications are invited for a two year course in in Special education – Multiple disabilities offered by Vidya Sagar, a 40-year-old, Chennai-based organisation working with people with disabilities. It is a full time regular course, on completion of which, the graduate can work in a mainstream school or a special school, start their own rehab center, take up Teacher Eligibility Test for government jobs, or do higher studies and get into research. This course is affiliated to the Tamil Nadu Teacher Education University, has the equivalence of General education and is recognised by the Rehabilitation Council of India. To know more, contact 9840035203 or mail hrd@
Time of India
9 hours ago
- Time of India
Axiom-4 astronauts to study insulin behaviour in microgravity, revolutionise diabetes treatment
New Delhi: Indian astronaut Shubhanshu Shukla's Axiom-4 mission to the International Space Station (ISS) is set to offer a ray of hope for diabetics to travel to space, as a UAE-based healthcare provider is conducting an experiment on how glucose behaves in microgravity part of the "Suite Ride" experiment planned by Burjeel Holdings and Axiom Space, some astronauts of the Axiom-4 mission will be wearing continuous glucose monitors during their 14-day stay on board the orbital lab. The studies of the behaviour of glucose and insulin in microgravity conditions will help scientists develop wearable technologies for astronauts and patients who are bedridden or have limited mobility due to illnesses such as paralysis. "We are trying just to see if there is any change or fluctuation to the blood-sugar levels while they are in space," Mohammad Fityan, chief medical officer at Burjeel Holdings, Abu Dhabi, told PTI. The astronauts will also carry insulin pens in refrigerated and ambient temperatures to examine how the molecules respond to microgravity conditions. "We are hoping that if we learn something about the metabolism or the effect, we will bring some information and we can do something for our patients on Earth," Fityan said. Currently, the National Aeronautics and Space Administration (NASA) does not allow insulin-dependent diabetics to travel to space. There are no official exclusions for non-insulin-dependent diabetics, but so far, no astronaut with diabetes has travelled to space. "It has the potential to transform the future of space travel for astronauts with insulin-dependent diabetes mellitus (IDDM), a condition historically considered disqualifying for space missions," Fityan said. He said the study will pave the way for several innovative technologies and treatment approaches for developing advanced glucose-monitoring tools optimised for extreme or low-activity environments, improving wearable tech for both astronauts and patients with limited mobility on Earth. It will also help identify new pharmacologic targets by observing how metabolic and hormonal responses change in microgravity, leading to drugs that enhance insulin sensitivity or mimic the benefits of exercise in sedentary individuals. The AI-powered predictive models based on real-time physiologic data in space can be adapted to personalise diabetes care on Earth by forecasting insulin needs or metabolic shifts with higher accuracy. The research will also help develop remote monitoring platforms for continuous metabolic-data capture that could revolutionise diabetes care in underserved or remote areas on Earth as well as in tele-health settings.
